In this section you will find reports from our International Drug Testing Service and links to our most relevant peer-reviewed scientific articles,  interventions in international congresses and other scientific forums, and conference posters.

Scientific research

Peer-reviewed articles:

Updating the list of known opioids through identification and characterization of the new opioidderivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900).

Fabregat-Safont D, Carbón X, Ventura M, Fornís I, Guillamón EM, Sancho J, Hernández F, Ibáñez M

Scientific reports. 2017. 24;7(1):6338. doi: 10.1038/s41598-017-06778-9.

The utility of drug checking services as monitoring tools and more: A response to Pirona et al.

Vidal-Giné C, Ventura M, Measham F, Brunt T, Bücheli A, Paulos C, Valente H, Martins D, Libois B, Tögel-Lins K, Jones G, Karden A, Barratt M

International Journal of Drug Policy 45 (2017) 46–47. doi: 10.1016/j.drugpo.2017.05.018

The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal’s Boom Festival.

Martins D, Barratt M, Vale Pires C, Carvalho H, Ventura M, Fornís I, Valente H

Human Psychopharmacology: Clinical and experimental. 2017. Volume 32, Issue 3. doi: 10.1002/hup.2608

Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone).

Grifell M, Ventura M, Carbón X, Quintana P, Galindo L, Palma A, Fornis I, Gil C, Farre M, Torrens M.

Human Psychopharmacology: Clinical and experimental.  2017 May;32(3). doi: 10.1002/hup.2621.

Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis.

Palma-Conesa AJ , Ventura M, Galindo L, Fonseca F, Grifell M, Quintana P, Fornís I, Gil C, Farré M, Torrens M

Journal of Psychoactive Drugs. 2017 Jun 1:1-9. doi: 10.1080/02791072.2017.1320732.

Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain.

Fabregat-Safont D, Fornís I, Ventura M, Gil C, Calzada N, Sancho J, Hernández F, Ibáñez M

Drug Testing and Analysis. 2017 Mar 7. doi: 10.1002/dta.2182.

The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin

Quintana P, Ventura M, Grifell M, Palma A, Galindo L, Fornı́s I, Gil C, Carbón X, Caudevilla F, Farré M, Torrens M

Int J Drug Policy. 2017 Feb;40:78-83.

Results of an international drug testing service for cryptomarket users.

Caudevilla F, Ventura M, Fornís I, Barratt MJ, Vidal C, Lladanosa CG, Quintana P, Muñoz A, Calzada N

Int J Drug Policy. 2016 May 6. doi: 10.1016/j.drugpo.2016.04.017

Crystals and tablets in the Spanish ecstasy market 2000-2014: are they the same or different in terms of purity and adulteration?

Giné C, Ventura M, Fornís I, Gil C, Calzada N, Fitó A, Rodríguez J, Domingo A, de la Torre R

Forensic Science International 2016; 263:164-168.

Drug Testing in Europe: Monitoring Results of the Trans European Drug Information (T.E.D.I) Project.

Brunt T, Nagy C, Bücheli A, Martins D, Ugarte M, Beduwe C, Ventura M

Drug Testing and Analysis 2016. DOI 10.1002/dta.1954

The emergence of deep web marketplaces: a health perspective.

Caudevilla F

In: The internet and drug markets (European Monitoring Centre for Drugs and Drug Addiction: Insights 21) Publications Office of the European Union, Luxembourg 2016

New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?

Giné CV, Espinosa IF, Vilamala MV

Drug Testing and Analysis 2014;6(7-8):819-24

Presence and composition of cathinone derivatives in drug taken from a Drug Test Service in Spain (2010–2012)

Caudevilla Gálligo F, Ventura M, Indave Ruiz BI, Fornís I

Hum. Psychopharmacol Clin Exp 2013; 28: 341–344

Consumption of new psychoactive substances in a Spanish sample of research chemical users.

González D, Ventura M, Caudevilla F, Torrens M, Farré M

Hum. Psychopharmacol Clin Exp 2013; 28: 332–340.

 Nuevas drogas de síntesis en España: legal highs (2010-2012)

Fornís Espinosa I, Vidal Giné C, Caudevilla Gálligo F, Ventura Vilamala M

Med Clin (Barc). 2013;140:189-90.

Metanfetamina vendida como MDMA

Caudevilla F, Quintana P, Fornís I, Ventura M

Emergencias 2013; 25: 150-160

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects

Caudevilla F, Riba J, Ventura M, Gonzalez D, Farré M, Barbanoj MJ, Bouso JC

J Psychopharmacol. 2012 9, 46-56

Cocaína adulterada con levamisol: posibles implicaciones clínicas.

Ventura M, Caudevilla Gálligo F, Vidal Giné C, Grupo Investigadores SELECTO

Medicina Clínica 2011 Mar 26;136(8):367-8.

International congresses:

The challenges and opportunities for collaborating with substance testing services

Ventura, M

Testing Times. University of Manchester  1 June 2017

Results of an international drug testing service for cryptomarket users

Ventura, M

25th Harm Reduction International Conference. 15 May 2017 Montreal

Risk and Harm Reduction in Deep Web

Caudevilla F

Boom Festival, Liminal Village. 14 Aug 2016

The evolution of novel psychoactive substances in Spanish recreational settings: type of substances consumed and trends detected after 10 years of monitoring

Ventura, M

Fourth international conference on novel psychoactive substances. 30-31 May 2016 Budapest

New Psychoactive Substances (NPS)  in Deep Web Marketplaces (DWM): Innovative approaches to New Psychoactive Substances

Caudevilla F

New Psychoactive Substances Seminary, 18 Oct 2015 Lisbon

Deep Web Marketplaces: an opportunity for Harm Reduction

Caudevilla F

International Drug Reform Policy Conference.22 Nov 2015 Washington

Internet, Undernet and Harm Reduction

Caudevilla F

International Harm Reduction Conference 2015. 22 October 2015 Kuala Lumpur

A Spanish Drug Checking service for recreational drug users

Ventura, M.

Journée Safer Nightlife Suisse. 24th September 2015, Lausanne

The importance of NPS in online drug markets: data from Silk Road 2.0

Caudevilla, F

Third international conference on novel psychoactive substances, 15 May 2014, Rome

Novel Psychoactive substances as adulterants of controlled drugs

Ventura, M.

Third international conference on novel psychoactive substances, 15th May 2014, Rome

Subjective, adverse effects and presence of psychedelic phenethylamines (“2C-X”) in the recreational Spanish drug market (2006-2011)

Caudevilla F

First International Congress on Novel Psychoactive Substances. 14 March 2012 Budapest.

Drug Checking tutorial

Quintana, P., López, S., Ventura, M.

Nights 2013: Health, pleasure and communities. 24th September 2013 Padova.

Drug Checking programs as a harm reduction strategy

Ventura, M.

1st Forum Science and Society dialogue in the field of drugs. 4th December 2012 Brussels

Risk reduction on new drugs, a Spanish experience

Fornís, I.

First International Conference on Novel Psychoactive Substances. 14 March 2012 Budapest.

PMMA in Legal Highs in Spain

Fornís, I.

CLUB HEALTH CONFERENCE 2011. The 7th international conference on Nightlife, Substance Use and related Health Issues. 12nd-14th December 2011 Praga.

Drug checking service: an effective strategy for contacting with drug users and detecting new trends

Ventura, M.

CLUB HEALTH CONFERENCE 2010. The 6th international conference on Nightlife, Substance Use and related Health Issues. 9th June 2010 Zurich.

Conference posters:

Evolution of the composition of cannabis in Spain

L. Galindo, P. Quintana, M. Grifell, A. Palma, C. Gil, I. Fornis, M. Ventura, F. Caudevilla, M. Torrens, M. Farré

Poster presented at: 29th ECNP Congress, 17-20 September 2016, Vienna, Austria

Ocfentanil: a novel fentanyl derivative detected as an adulterant of Heroin

P. Quintana, M. Ventura, M. Grifell, A. Palma, L. Galindo, I. Fornís, C. Gil, X. Carbón, F. Caudevilla, M. Farré, M. Torrens

Poster presented at: Fourth international conference on novel psychoactive substances. 30-31 May Budapest 2016.

The synthetic cannabinoids: JWH, four years of analysis

L.Galindo, M.Grifell, P.Quintana, A. Palma, J. Tirado, M.Ventura, C.Gil, I.Fornís, M.Torrens, M.Farré.

Poster presented at: 24th European Congress of Psychiatry. 12-15 March 2016 Madrid.

Methylone consumption characterized through samples handled by users.

L. Martinez,  M. Grifell, L. Galindo, I. Ezquiaga, P. Quintana, M. Angelats, A. Palma, M. Ventura, I. Fornís, M. Torrens, M. Farré

Poster presented at: 24th European Congress of Psychiatry. 12-15 March 2016 Madrid, Spain.

Presence of DOB (2,5-­Dimethoxy-­4-Bromoamphetamine) among samples submitted to a Drug Checking service in Spain

P. Quintana, M. Grifell, Á. Palma, C. Gil, I. Fornís, L. Galindo, M. Torrens, M. Farré, M. Ventura

Poster presented at: 24th European Congress of Psychiatry. 12-15 March 2016 Madrid, Spain.

Presence of Methylphenidate in the illegal drug market: analysis of samples submitted to a drug checking facility

P. Quintana, M. Grifell, Á. Palma, C. Gil, I. Fornís, L. Galindo, M. Farré, M. Ventura, M. Torrens

Poster presented at: 24th European Congress of Psychiatry. 12-15 March 2016 Madrid, Spain.

A trip to the unknown: 2,5-Dimethoxy-4-chloroamphetamine (DOC) sold as LSD: study on samples delivered by users asking for substance analysis.

M. Grifell, A. Palma, M. Ventura, I. Fornís, F. Dinamarca, M. Torrens, L. Galindo, V. Pérez, P. Quintana, L. González, M. Farré

Poster presented at: 28th ECNP congress. 29th August-1st September 2015, Amsterdam

Is this really ketamine? The presence of methoxetamine on drug samples delivered as ketamine for substance analysis.

P. Quintana, Á. Palma, M. Grifell, J. Tirado, C. Gil, M. Ventura, I. Fornís, S. López, V. Perez, M. Torrens, M. Farré, L. Galindo

Poster presented at: 28th ECNP congress. 29th August-1st September 2015, Amsterdam.

An old chemical that became a new psychoactive substance: study on O-Acetylpsilocin samples handled for analysis and raise of awareness

A. Palma, L. Galindo, M. Grifell, P. Quintana, A. Toll, M. Ventura, I.Fornís, M. Torrens, M. Farré, F. Fonseca

Poster presented at: 28th ECNP congress. 29th August-1st September 2015, Amsterdam.

Reviewing ‘Apinaca’, an emergent synthetic cannabinoid receptor agonist

FN. Dinamarca, L. Galindo, M. Grifell, M. Campillo, V. Pérez, M. Torrens, M. Farré

Poster presented at: 28th ECNP congress. 29th August-1st September 2015, Amsterdam.

Intervención on-line en consumidores de drogas que solicitan asesoramiento médico

M. Grifell, L. Galindo, P. Quintana, A. Palma, I. Fornís, M. Ventura, L. González, F. Caudevilla

Poster presentado en: XVIII Congreso Nacional de Psiquiatria. 24-26 Setiembre 2015, Santiago de Compostela.

TLC: Old Friends, New Possibilities

P. Quintana, S. López, I. Fornís, M. Ventura

Poster presented at: NIGHTS congress 2013, 25th-27th September 2013 Padova